Indivior Reaches $102.5M Settlement To Resolve Antitrust Litigation
Indivior PLC (OTCPK:INVVY) (OTCPK:IZQVF) (LSE: NDV), an addiction treatment company, announced that its subsidiary, Indivior Inc., has reached an agreement to resolve the claims brought by the Attorneys General of 41 states and the District of Columbia ("the claimants") in the In re Suboxone Antitrust Litigation multi-district litigat
